Innovation Pharmaceuticals Inc (IPIX)

[thefamilyman]

It looks like the Pfizer drug is competition for Merck’s mutagenic drug. Both of which are for use early in the disease.

LilKahuna said,

The selling was nothing more than market reaction to the Pfizer news. The problem is, the drug is expensive. It’s fine for wealthier countries, but the rest of the world, the other 6 billion people, need a cheaper, effective treatment. Brilacidin is still in the running in dozens of markets.